Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines

S. H. Park, J. H. Sung, E. J. Kim, Namhyun Chung

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Pancreatic cancer is the fourth leading cause of cancer death. Gemcitabine is widely used as a chemotherapeutic agent for the treatment of pancreatic cancer, but the prognosis is still poor. Berberine, an isoquinoline alkaloid extracted from a variety of natural herbs, possesses a variety of pharmacological properties including anticancer effects. In this study, we investigated the anticancer effects of berberine and compared its use with that of gemcitabine in the pancreatic cancer cell lines PANC-1 and MIA-PaCa 2. Berberine inhibited cell growth in a dose-dependent manner by inducing cell cycle arrest and apoptosis. After berberine treatment, the G1 phase of PANC-1 cells increased by 10% compared to control cells, and the G1 phase of MIA-PaCa2 cells was increased by 2%. Whereas gemcitabine exerts antiproliferation effects through S-phase arrest, our results showed that berberine inhibited proliferation by inducing G1-phase arrest. Berberine-induced apoptosis of PANC-1 and MIA-PaCa2 cells increased by 7 and 2% compared to control cells, respectively. Notably, berberine had a greater apoptotic effect in PANC-1 cells than gemcitabine. Upon treatment of PANC-1 and MIA-PaCa2 with berberine at a half-maximal inhibitory concentration (IC50), apoptosis was induced by a mechanismthat involved the production of reactive oxygen species (ROS) rather than caspase 3/7 activation. Our findings showed that berberine had anti-cancer effects and may be an effective drug for pancreatic cancer chemotherapy.

Original languageEnglish
Pages (from-to)111-119
Number of pages9
JournalBrazilian Journal of Medical and Biological Research
Volume48
Issue number2
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Berberine
gemcitabine
Reactive Oxygen Species
Cells
Apoptosis
Cell Line
Pancreatic Neoplasms
G1 Phase
Berberine Alkaloids
Caspase 7
Chemotherapy
Cell Cycle Checkpoints
S Phase
Cell growth
Caspase 3
Inhibitory Concentration 50
Alkaloids
Cause of Death
Neoplasms
Therapeutics

Keywords

  • Apoptosis
  • Berberine
  • Cell cycle arrest
  • Gemcitabine
  • Pancreatic cancer

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Cell Biology
  • Physiology
  • Immunology
  • Medicine(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines. / Park, S. H.; Sung, J. H.; Kim, E. J.; Chung, Namhyun.

In: Brazilian Journal of Medical and Biological Research, Vol. 48, No. 2, 01.01.2015, p. 111-119.

Research output: Contribution to journalArticle

@article{809de9e75da1455facb5d96bf29ce94d,
title = "Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines",
abstract = "Pancreatic cancer is the fourth leading cause of cancer death. Gemcitabine is widely used as a chemotherapeutic agent for the treatment of pancreatic cancer, but the prognosis is still poor. Berberine, an isoquinoline alkaloid extracted from a variety of natural herbs, possesses a variety of pharmacological properties including anticancer effects. In this study, we investigated the anticancer effects of berberine and compared its use with that of gemcitabine in the pancreatic cancer cell lines PANC-1 and MIA-PaCa 2. Berberine inhibited cell growth in a dose-dependent manner by inducing cell cycle arrest and apoptosis. After berberine treatment, the G1 phase of PANC-1 cells increased by 10{\%} compared to control cells, and the G1 phase of MIA-PaCa2 cells was increased by 2{\%}. Whereas gemcitabine exerts antiproliferation effects through S-phase arrest, our results showed that berberine inhibited proliferation by inducing G1-phase arrest. Berberine-induced apoptosis of PANC-1 and MIA-PaCa2 cells increased by 7 and 2{\%} compared to control cells, respectively. Notably, berberine had a greater apoptotic effect in PANC-1 cells than gemcitabine. Upon treatment of PANC-1 and MIA-PaCa2 with berberine at a half-maximal inhibitory concentration (IC50), apoptosis was induced by a mechanismthat involved the production of reactive oxygen species (ROS) rather than caspase 3/7 activation. Our findings showed that berberine had anti-cancer effects and may be an effective drug for pancreatic cancer chemotherapy.",
keywords = "Apoptosis, Berberine, Cell cycle arrest, Gemcitabine, Pancreatic cancer",
author = "Park, {S. H.} and Sung, {J. H.} and Kim, {E. J.} and Namhyun Chung",
year = "2015",
month = "1",
day = "1",
doi = "10.1590/1414-431X20144293",
language = "English",
volume = "48",
pages = "111--119",
journal = "Brazilian Journal of Medical and Biological Research",
issn = "0100-879X",
publisher = "Associacao Brasileira de Divulgacao Cientifica",
number = "2",

}

TY - JOUR

T1 - Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines

AU - Park, S. H.

AU - Sung, J. H.

AU - Kim, E. J.

AU - Chung, Namhyun

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Pancreatic cancer is the fourth leading cause of cancer death. Gemcitabine is widely used as a chemotherapeutic agent for the treatment of pancreatic cancer, but the prognosis is still poor. Berberine, an isoquinoline alkaloid extracted from a variety of natural herbs, possesses a variety of pharmacological properties including anticancer effects. In this study, we investigated the anticancer effects of berberine and compared its use with that of gemcitabine in the pancreatic cancer cell lines PANC-1 and MIA-PaCa 2. Berberine inhibited cell growth in a dose-dependent manner by inducing cell cycle arrest and apoptosis. After berberine treatment, the G1 phase of PANC-1 cells increased by 10% compared to control cells, and the G1 phase of MIA-PaCa2 cells was increased by 2%. Whereas gemcitabine exerts antiproliferation effects through S-phase arrest, our results showed that berberine inhibited proliferation by inducing G1-phase arrest. Berberine-induced apoptosis of PANC-1 and MIA-PaCa2 cells increased by 7 and 2% compared to control cells, respectively. Notably, berberine had a greater apoptotic effect in PANC-1 cells than gemcitabine. Upon treatment of PANC-1 and MIA-PaCa2 with berberine at a half-maximal inhibitory concentration (IC50), apoptosis was induced by a mechanismthat involved the production of reactive oxygen species (ROS) rather than caspase 3/7 activation. Our findings showed that berberine had anti-cancer effects and may be an effective drug for pancreatic cancer chemotherapy.

AB - Pancreatic cancer is the fourth leading cause of cancer death. Gemcitabine is widely used as a chemotherapeutic agent for the treatment of pancreatic cancer, but the prognosis is still poor. Berberine, an isoquinoline alkaloid extracted from a variety of natural herbs, possesses a variety of pharmacological properties including anticancer effects. In this study, we investigated the anticancer effects of berberine and compared its use with that of gemcitabine in the pancreatic cancer cell lines PANC-1 and MIA-PaCa 2. Berberine inhibited cell growth in a dose-dependent manner by inducing cell cycle arrest and apoptosis. After berberine treatment, the G1 phase of PANC-1 cells increased by 10% compared to control cells, and the G1 phase of MIA-PaCa2 cells was increased by 2%. Whereas gemcitabine exerts antiproliferation effects through S-phase arrest, our results showed that berberine inhibited proliferation by inducing G1-phase arrest. Berberine-induced apoptosis of PANC-1 and MIA-PaCa2 cells increased by 7 and 2% compared to control cells, respectively. Notably, berberine had a greater apoptotic effect in PANC-1 cells than gemcitabine. Upon treatment of PANC-1 and MIA-PaCa2 with berberine at a half-maximal inhibitory concentration (IC50), apoptosis was induced by a mechanismthat involved the production of reactive oxygen species (ROS) rather than caspase 3/7 activation. Our findings showed that berberine had anti-cancer effects and may be an effective drug for pancreatic cancer chemotherapy.

KW - Apoptosis

KW - Berberine

KW - Cell cycle arrest

KW - Gemcitabine

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=84922252926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922252926&partnerID=8YFLogxK

U2 - 10.1590/1414-431X20144293

DO - 10.1590/1414-431X20144293

M3 - Article

C2 - 25517919

AN - SCOPUS:84922252926

VL - 48

SP - 111

EP - 119

JO - Brazilian Journal of Medical and Biological Research

JF - Brazilian Journal of Medical and Biological Research

SN - 0100-879X

IS - 2

ER -